Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP838374.RATzmMUYPRx-dI48pjiEUd5VkixXtr5v4Gk_9lUYn-tOA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP838374.RATzmMUYPRx-dI48pjiEUd5VkixXtr5v4Gk_9lUYn-tOA130_assertion type Assertion NP838374.RATzmMUYPRx-dI48pjiEUd5VkixXtr5v4Gk_9lUYn-tOA130_head.
- NP838374.RATzmMUYPRx-dI48pjiEUd5VkixXtr5v4Gk_9lUYn-tOA130_assertion description "[Inhibitors of the mammalian target of rapamycin (mTOR) are emerging as promising therapies for metastatic renal cell carcinoma (RCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP838374.RATzmMUYPRx-dI48pjiEUd5VkixXtr5v4Gk_9lUYn-tOA130_provenance.
- NP838374.RATzmMUYPRx-dI48pjiEUd5VkixXtr5v4Gk_9lUYn-tOA130_assertion evidence source_evidence_literature NP838374.RATzmMUYPRx-dI48pjiEUd5VkixXtr5v4Gk_9lUYn-tOA130_provenance.
- NP838374.RATzmMUYPRx-dI48pjiEUd5VkixXtr5v4Gk_9lUYn-tOA130_assertion SIO_000772 20830770 NP838374.RATzmMUYPRx-dI48pjiEUd5VkixXtr5v4Gk_9lUYn-tOA130_provenance.
- NP838374.RATzmMUYPRx-dI48pjiEUd5VkixXtr5v4Gk_9lUYn-tOA130_assertion wasDerivedFrom befree-2016 NP838374.RATzmMUYPRx-dI48pjiEUd5VkixXtr5v4Gk_9lUYn-tOA130_provenance.
- NP838374.RATzmMUYPRx-dI48pjiEUd5VkixXtr5v4Gk_9lUYn-tOA130_assertion wasGeneratedBy ECO_0000203 NP838374.RATzmMUYPRx-dI48pjiEUd5VkixXtr5v4Gk_9lUYn-tOA130_provenance.